Dr. Kitti Kaiboriboon is a Seattle, Washington based neurologist with 29 years of experience in Neurology. He completed his graduation in 1995. He is also affiliated with hospitals like and . He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Kitti Kaiboriboon is 60508358 for Neurology in Washington. His current practice location is 550 17th Ave, Suite 540, Seattle. Patients can reach him at 206-386-3880 or can fax him at 206-386-3882. Dr. Kitti Kaiboriboon is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1912062035. Dr. Kitti Kaiboriboon specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Kitti Kaiboriboon speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Kitti Kaiboriboon
Specialization:
Neurology
Gender:
Male
Credentials:
M.D.
Experience:
29+ years
Medical School Attended:
Other
Graduation Year:
1995
Accepts Medicare Assignment:
Yes
Practice Address:
550 17th Ave, Suite 540, Seattle, Washington, 98122-5788
Phone:
206-386-3880
Fax:
206-386-3882
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
4284731027
Enrollment ID:
I20150130000742
NPI Number:
1912062035
NPI Enumeration Date:
27 Dec, 2006
NPI Last Update On:
15 Jun, 2021
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Kitti Kaiboriboon are as mentioned below.
License Number
Specialization
State
Status
60508358
Neurology
Washington
Primary
35.093501
Neurology
Ohio
Secondary
2006038718
Neurology
Missouri
Secondary
A83409
Neurology
California
Secondary
60508358
Clinical Neurophysiology
Washington
Secondary
A83409
Clinical Neurophysiology
California
Secondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
(500025)
Seattle, WA
Acute Care Hospital
(500014)
Everett, WA
Acute Care Hospital
(020001)
Anchorage, AK
Acute Care Hospital
(500152)
Issaquah, WA
Acute Care Hospital
(500027)
Seattle, WA
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Kitti Kaiboriboon is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Providence Health And Services - Wa (8325100480)
401
Providence Health And Services Washington (1557408176)
129
Providence Medical Institute (5991609737)
274
Swedish Health Services (0244138196)
819
Other Medical Identifiers:
Other legacy medical identifiers associated with Dr. Kitti Kaiboriboon such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
2941473
Medicaid
Ohio
P00794607
Other
Ohio
MEDICARE RAILROAD
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Kitti Kaiboriboon Po Box 25608, Salt Lake City, Utah
Zip:
84125-0608
Phone Number:
206-320-4476
Fax Number:
206-568-7043
Patients can reach Dr. Kitti Kaiboriboon at 550 17th Ave, Suite 540, Seattle, Washington or can call to book an appointment on 206-386-3880.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.